Cline Scientific AB (OSTO:CLINE B) ROCE % : 2.68% (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Cline Scientific AB ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Cline Scientific AB's annualized ROCE % for the quarter that ended in Dec. 2023 was 2.68%.

Cline Scientific AB ROCE % Historical Data

The historical data trend for Cline Scientific AB's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cline Scientific AB ROCE % Chart

Cline Scientific AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-40.54

-23.08

-24.60

-12.93

-15.87

Cline Scientific AB Semi-Annual Data
	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROCE %	Get a 7-Day Free Trial												-1.63	-31.39	2.85	-40.37	2.68

Cline Scientific AB ROCE % Calculation

Cline Scientific AB's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-3.109	/	( ( (18.817 - 0.542)	+	(22.721 - 1.804) )	/ 2 )
	=	-3.109	/	( (18.275	+	20.917)	/ 2 )
	=	-3.109	/	19.596
	=	-15.87 %

Cline Scientific AB's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	0.48	/	( ( (14.974 - 0.065)	+	(22.721 - 1.804) )	/ 2 )
	=	0.48	/	( ( 14.909	+	20.917 )	/ 2 )
	=	0.48	/	17.913
	=	2.68 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

Cline Scientific AB (OSTO:CLINE B) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Cline Scientific AB ROCE % Related Terms

Thank you for viewing the detailed overview of Cline Scientific AB's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Cline Scientific AB (OSTO:CLINE B) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cline Scientific AB (OSTO:CLINE B) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Vastra Gotalands Lan, 2C Argongatan, Molndal, SWE, 43153

Website

http://www.clinescientific.com

Cline Scientific AB develops and markets products for biomedical research based on proprietary nanotechnology. Its products include unique surfaces for use in stem cell & cancer research and customized nanoparticles for use in biomedical applications.

Cline Scientific AB (OSTO:CLINE B) Headlines

No Headlines